Osteal Therapeutics Closes $50M Series D Financing to Support Approval and Commercial Launch of Lead Candidate
BioPharma
Stay updated with breaking news from Jjdc Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Global licensing, co-development, and commercialization agreement with Janssen Pharmaceutica NV (“Janssen”) expands worldwide potential of novel...
Global licensing, co-development, and commercialization agreement with Janssen Pharmaceutica NV expands worldwide potential of novel radioenhancer NBTXR3Prolonged survival in Study 102 reinforces...
Global licensing, co-development, and commercialization agreement with Janssen Pharmaceutica NV (“Janssen”) expands worldwide potential of novel radioenhancer NBTXR3Prolonged survival in Study 102 reinforces pivotal NANORAY-312 trial design in head and
Biotech Stocks in Play - Rallybio Corporation (Nasdaq: RLYB) Soars on Collaboration News and Equity Investment of $6.6 million from Johnson & Johnson Innovation